Successful treatment of periodic disease and secondary AA amyloidosis in a colchicine-resistant patient

Abstract

The paper demonstrates current opportunities of effective management of periodic disease as an autoinflammatory disorder based on a clinical case of colchicine-resistant Mediterranean fever. We present modern approaches to the autoinflammation hypothesis and its molecular mechanisms in periodic disease. Based on literature and our own research results, we consider approaches to evaluate autoinflammation activity and to monitor treatment efficacy. Clinical value of S100A12, a novel marker of the activity of neutrophilic autoinflammation, is demonstrated.

Keywords

• autoinflammation
• interleukin 1
• pyrine
• inflammasome
• periodic disease
• mediterranean fever
• colchicine
• canakinumab
• amyloidosis aa